HomeCOEP • NASDAQ
add
Coeptis Therapeutics Holdings Inc
Previous close
$16.42
Day range
$15.63 - $16.62
Year range
$2.31 - $21.41
Market cap
83.84M USD
Avg Volume
58.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 237.44K | — |
Operating expense | 2.67M | 24.63% |
Net income | -2.74M | -58.11% |
Net profit margin | -1.15K | — |
Earnings per share | — | — |
EBITDA | -2.18M | -15.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.33M | 368.61% |
Total assets | 14.18M | 58.35% |
Total liabilities | 3.26M | -17.84% |
Total equity | 10.92M | — |
Shares outstanding | 5.34M | — |
Price to book | 8.17 | — |
Return on assets | -46.96% | — |
Return on capital | -63.16% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -2.74M | -58.11% |
Cash from operations | -2.15M | -13.72% |
Cash from investing | — | — |
Cash from financing | 5.06M | 243.32% |
Net change in cash | 2.91M | 797.22% |
Free cash flow | -1.70M | -76.58% |
About
Founded
2017
Headquarters
Website
Employees
6
